Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1944 1
1947 2
1952 1
1953 1
1954 1
1956 2
1957 1
1958 1
1959 2
1962 1
1963 1
1964 5
1965 3
1966 2
1967 1
1968 1
1970 4
1974 2
1976 1
1978 2
1983 1
1984 3
1985 4
1986 4
1990 1
1992 4
1994 1
1995 4
1996 2
1997 8
1998 7
1999 2
2000 3
2001 7
2002 4
2003 4
2004 2
2005 4
2006 7
2007 5
2008 6
2009 2
2010 3
2011 8
2012 8
2013 5
2014 7
2015 8
2016 7
2017 11
2018 11
2019 19
2020 19
2021 16
2022 7
Text availability
Article attribute
Article type
Publication date

Search Results

230 results
Results by year
Filters applied: . Clear all
Page 1
Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate is Non-inferior to Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-naive Adults With Human Immunodeficiency Virus-1 Infection: Week 48 Results of the DRIVE-AHEAD Trial.
Orkin C, Squires KE, Molina JM, Sax PE, Wong WW, Sussmann O, Kaplan R, Lupinacci L, Rodgers A, Xu X, Lin G, Kumar S, Sklar P, Nguyen BY, Hanna GJ, Hwang C, Martin EA; DRIVE-AHEAD Study Group. Orkin C, et al. Among authors: martin ea. Clin Infect Dis. 2019 Feb 1;68(4):535-544. doi: 10.1093/cid/ciy540. Clin Infect Dis. 2019. PMID: 30184165 Free PMC article. Clinical Trial.
Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 96-week results of a randomised, double-blind, non-inferiority, phase 3 trial.
Molina JM, Squires K, Sax PE, Cahn P, Lombaard J, DeJesus E, Lai MT, Rodgers A, Lupinacci L, Kumar S, Sklar P, Hanna GJ, Hwang C, Martin EA; DRIVE-FORWARD trial group. Molina JM, et al. Among authors: martin ea. Lancet HIV. 2020 Jan;7(1):e16-e26. doi: 10.1016/S2352-3018(19)30336-4. Epub 2019 Nov 15. Lancet HIV. 2020. PMID: 31740348 Clinical Trial.
Emotional processing in schizophrenia.
Kohler CG, Martin EA. Kohler CG, et al. Among authors: martin ea. Cogn Neuropsychiatry. 2006 May;11(3):250-71. doi: 10.1080/13546800500188575. Cogn Neuropsychiatry. 2006. PMID: 17354071 Review.
Calculating qualified non-mutagenic impurity levels: Harmonization of approaches.
Graham JC, Powley MW, Udovic E, Glowienke S, Nicolette J, Parris P, Kenyon M, White A, Maisey A, Harvey J, Martin EA, Dowdy E, Masuda-Herrera M, Trejo-Martin A, Bercu J. Graham JC, et al. Among authors: martin ea. Regul Toxicol Pharmacol. 2021 Nov;126:105023. doi: 10.1016/j.yrtph.2021.105023. Epub 2021 Aug 4. Regul Toxicol Pharmacol. 2021. PMID: 34363920
Changes in weight and BMI with first-line doravirine-based therapy.
Orkin C, Elion R, Thompson M, Rockstroh JK, Alvarez Bognar F, Xu ZJ, Hwang C, Sklar P, Martin EA. Orkin C, et al. Among authors: martin ea. AIDS. 2021 Jan 1;35(1):91-99. doi: 10.1097/QAD.0000000000002725. AIDS. 2021. PMID: 33048879 Free PMC article.
Reply to Lanzafame et al.
Martin EA, Hwang C, Orkin C. Martin EA, et al. Clin Infect Dis. 2019 Oct 30;69(10):1832-1833. doi: 10.1093/cid/ciz229. Clin Infect Dis. 2019. PMID: 30891586 No abstract available.
MRPC: An R Package for Inference of Causal Graphs.
Badsha MB, Martin EA, Fu AQ. Badsha MB, et al. Among authors: martin ea. Front Genet. 2021 Apr 30;12:651812. doi: 10.3389/fgene.2021.651812. eCollection 2021. Front Genet. 2021. PMID: 33995486 Free PMC article.
230 results